[ TRANSACTION RECORD ]

Bristol Myers Squibb Investment in BMS Karuna Platform — 2023

VERIFIED VECTOR ID: 002216 · tx-312
M SOURCE NODE — FUNDER
Bristol Myers Squibb
Healthcare United States
$14,000,000,000
EQUITY
22/12/2023
Q DESTINATION NODE — RECIPIENT
BMS Karuna Platform
SPV United States
Amount (USD)
$14.0B
Flow Type
EQUITY
Transaction Date
22/12/2023
Primary Source
View Filing ↗
Funder Profile [ M ]
Entity Bristol Myers Squibb
AUM 110000
HQ Location United States
Sector Healthcare
Recipient Profile [ Q ]
Entity BMS Karuna Platform
Entity Type SPV
Jurisdiction United States
Intelligence Note

Bristol Myers Squibb entered into an agreement to acquire Karuna Therapeutics for 14 billion dollars to expand its presence in neuroscience and psychiatric drug development. This transaction centers on novel treatments for schizophrenia and other complex brain disorders. This deal highlights the high institutional value of transformative neurological therapies in the global healthcare and biotech market.

Σ
Primary Forensic Source https://news.bms.com/news/details/2023/Bristol-Myers-Squibb-to-Acquire-Karuna-Therapeutics/
✓ SOURCE LINKED